Adaptimmune Therapeutics PLC 10-K for FY2023
Adaptimmune Therapeutics PLC (ADAPY)
10-K
2024-03-06
For: 2023-12-31
View Original
Added on
June 11, 2026
About this 10-K
Adaptimmune Therapeutics PLC filed this 10-K on March 6, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $60.28M
- up 122.0% from $27.15M a year earlier
- Net loss
- $113.87M
- compared with a net loss of $165.46M a year earlier
- Diluted EPS
- -$0.09
- compared with -$0.17 a year earlier